A major biotechnology company has leased around 500,000 sq ft of space in Hyderabad to set up its first global capability centre (GCC), effectively doubling its office footprint in the city, according to people familiar with the development.

In the first phase, the organisation has taken up 2.5 lakh sq ft, with an additional 2.5 lakh sq ft to be occupied in phase two, expected to be operational by the end of 2025. The lease tenure is nine years with a five-year lock-in period, and the rental cost is approximately ?90 per sq ft.

The new GCC will focus on building advanced technology and digital capabilities to enhance efficiencies across global operations. It will leverage technology, artificial intelligence (AI), and data analytics to drive innovation, streamline processes, and accelerate research efforts.

Hyderabad continues to strengthen its position as a leading hub for life sciences and technology, consistently drawing large-scale investments from global corporations. Recently, multiple multinational healthcare and biotech companies have announced sizable investments to expand or establish their GCCs in the city.

India’s biotechnology sector is projected to contribute 19% to the global biotech market by 2025, supported by strong cost competitiveness, a growing bioeconomy, and strategic advantages. The sector is expected to surpass $300 billion by 2030.

https://www.livehomes.in/news_letter